Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy
Status:
Terminated
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
Blood loss was reported as a prognostic risk factor of morbidity and overall survival after
hepatic resection. The aim of this study prospective randomized was compare the efficacy of
the administration of tranexamic acid versus placebo to reduce perioperative bleeding after
major hepatectomy (> 3 hepatic segments).